RAN and Hypoinsulinemia: Unexpectedly, we found that deregulated Ran signaling under these conditions dramatically impairs postnatal, but not embryonic islet development, triggering hypoinsulinemia, reduced β cell proliferation and overt diabetes, in vivo.